BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17668454)

  • 21. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
    Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
    J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent adenosine antagonists].
    Suzuki F; Shimada J
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1277-92. PubMed ID: 7568926
    [No Abstract]   [Full Text] [Related]  

  • 24. QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists.
    Massarelli I; Coi A; Pietra D; Nofal FA; Biagi G; Giorgi I; Leonardi M; Fiamingo F; Bianucci AM
    Eur J Med Chem; 2008 Jan; 43(1):114-21. PubMed ID: 17418915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer-aided design of GPCR ligands.
    Gutiérrez-de-Terán H; Keränen H; Azuaje J; Rodríguez D; Åqvist J; Sotelo E
    Methods Mol Biol; 2015; 1272():271-91. PubMed ID: 25563191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
    Manetti F; Schenone S; Bondavalli F; Brullo C; Bruno O; Ranise A; Mosti L; Menozzi G; Fossa P; Trincavelli ML; Martini C; Martinelli A; Tintori C; Botta M
    J Med Chem; 2005 Nov; 48(23):7172-85. PubMed ID: 16279775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.
    Tafi A; Bernardini C; Botta M; Corelli F; Andreini M; Martinelli A; Ortore G; Baraldi PG; Fruttarolo F; Borea PA; Tuccinardi T
    J Med Chem; 2006 Jul; 49(14):4085-97. PubMed ID: 16821770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2'-furyl)-1,2,4-triazolo[1,5-a]quinoxalines.
    Martínez A; Gutiérrez-de-Terán H; Brea J; Raviña E; Loza MI; Cadavid MI; Sanz F; Vidal B; Segarra V; Sotelo E
    Bioorg Med Chem; 2008 Feb; 16(4):2103-13. PubMed ID: 18249548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands.
    Sirisha B; Narsaiah B; Yakaiah T; Gayatri G; Sastry GN; Prasad MR; Rao AR
    Eur J Med Chem; 2010 May; 45(5):1739-45. PubMed ID: 20116907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
    Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
    J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
    van Veldhoven JP; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Struensee-Link R; Beukers MW; Brussee J; IJzerman AP
    Bioorg Med Chem; 2008 Mar; 16(6):2741-52. PubMed ID: 18258439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity prediction on A1 adenosine receptor agonists: the chemometric approach.
    Fossa P; Mosti L; Bondavalli F; Schenone S; Ranise A; Casolino C; Forina M
    Bioorg Med Chem; 2006 Mar; 14(5):1348-63. PubMed ID: 16263293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: application to a lead optimization of a human A3 adenosine receptor antagonist.
    Moro S; Bacilieri M; Cacciari B; Bolcato C; Cusan C; Pastorin G; Klotz KN; Spalluto G
    Bioorg Med Chem; 2006 Jul; 14(14):4923-32. PubMed ID: 16564691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
    Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
    Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress towards novel adenosine receptor therapeutics gleaned from the recent patent literature.
    Press NJ; Fozard JR
    Expert Opin Ther Pat; 2010 Aug; 20(8):987-1005. PubMed ID: 20649373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative insights towards the design of potent deazaxanthine antagonists of adenosine 2B receptors.
    Paz OS; Brito CC; Castilho MS
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):590-8. PubMed ID: 24090420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects.
    Roncaglioni A; Benfenati E
    Chem Soc Rev; 2008 Mar; 37(3):441-50. PubMed ID: 18224255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines.
    Raghu Prasad M; Raghuram Rao A; Shanthan Rao P; Rajan KS; Meena S; Madhavi K
    Eur J Med Chem; 2008 Mar; 43(3):614-20. PubMed ID: 17602796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
    Pinheiro JR; Bitencourt M; da Cunha EF; Ramalho TC; Freitas MP
    Bioorg Med Chem; 2008 Feb; 16(4):1683-90. PubMed ID: 18053727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.